Table 2 NMSC subtypes localization on face based on sex.
From: Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study
Low-risk SCC | High-risk SCC | BSC | Low-risk BCC | High-risk BCC | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Men | ||||||||||
Nose | 28 | (21%) | 12 | (32%) | 24 | (44%) | 204 | (49%) | 24 | (44%) |
Eyehole | 6 | (4%) | 2 | (5%) | 8 | (15%) | 17 | (4%) | 7 | (13%) |
Cheek | 41 | (30%) | 9 | (24%) | 11 | (20%) | 153 | (37%) | 9 | (17%) |
Temple | 1 | (1%) | 1 | (3%) | 0 | (0%) | 9 | (2%) | 1 | (2%) |
Forehead | 1 | (1%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 0 | (0%) |
Earlobe | 42 | (31%)a | 9 | (24%)a | 9 | (16%)a | 19 | (5%) | 9 | (17%)a |
Lips | 15 | (11%) | 5 | (13%) | 2 | (4%) | 7 | (2%) | 2 | (4%) |
Chin | 2 | (1%) | 0 | (0%) | 1 | (2%) | 8 | (2%) | 2 | (4%) |
n/d | 89 | 9 | 26 | 133 | 215 | |||||
All | 225 | 47 | 81 | 549 | 269 | |||||
Women | ||||||||||
Nose | 46 | (28%) | 20 | (36%) | 20 | (42%) | 263 | (53%) | 46 | (60%) |
Eyehole | 3 | (2%) | 2 | (4%) | 10 | (21%) | 29 | (6%) | 5 | (6%) |
Cheek | 94 | (58%) | 25 | (45%) | 13 | (27%) | 163 | (33%) | 13 | (17%) |
Temple | 2 | (1%) | 1 | (2%) | 0 | (0%) | 10 | (2%) | 3 | (4%) |
Forehead | 1 | (1%) | 0 | (0%) | 0 | (0%) | 0 | (0%) | 0 | (0%) |
Earlobe | 5 | (3%)a | 2 | (4%)a | 3 | (6%)a | 9 | (2%) | 4 | (5%)a |
Lips | 10 | (6%) | 3 | (5%) | 2 | (4%) | 2 | (0%) | 0 | (0%) |
Chin | 2 | (1%) | 2 | (4%) | 0 | (0%) | 20 | (4%) | 6 | (8%) |
n/d | 112 | 27 | 20 | 53 | 219 | |||||
All | 275 | 82 | 68 | 549 | 296 | |||||
